A 39-year-old Caucasian man was referred to University Hospital Salamanca from a primary care unit due to the presence of an erythematous violaceous nodule at the superior portion of his nose. Physical examination indicated that the firm, fixed erythematous violaceous nodule measured approximately 2 cm in diameter and was located inferior to a scar on the nasal bridge. Cutaneous involvement in sarcoidosis occurs in 25% of cases. A wide range of clinical presentations of cutaneous sarcoidosis is recognized. Skin lesions are classified as either non-specific, of which erythema nodosum is the most representative and specific, or as granulomatous, which includes maculopapular nodules, plaques, infiltrated scars, lupus pernio, ulcerations, warty lesions and erythroderma. Scar sarcoidosis is a type of cutaneous sarcoidosis.
INTRODUCTION
Sarcoidosis is a granulomatous non-infectious disease with an unknown etiology and an ability to affect several organs, including the eyes, lymph nodules, bones, skin, and lungs. The most frequent sarcoidosis presentation involves the lungs and other internal organs.
Sarcoidosis usually occurs in young adults between 25 and 35 years of age as well as between 45 and 55 years of age. There is a greater prevalence of the disease among women. 1) Cutaneous sarcoidosis is known as a 'great simulator' of other diseases due to its polymorphic lesion appearance 2) as well as its complex and varied range of clinical presentation. Meanwhile, cicatricial sarcoidosis is rare, does not always present in a manner that is characteristic of cutaneous sarcoidosis, and represents a major diagnostic challenge. 3, 4) Therefore, clinical suspicion is necessary to correctly diagnose the condition.
CASE REPORT
A white male of 39 years of age was referred to University Hospital Salamanca from a primary care unit due to the presence of an erythema- 
disCussion
Sarcoidosis is a multisystem disorder whose cause is unknown. Nevertheless, it is characterized by the presence of a non-caseating inflammatory granuloma. Despite extensive research, the etiology of sarcoidosis has not yet been elucidated, although most evidence supports that the pathogenic mechanism of sarcoidosis is an aberrant immune response that is driven by an unidentified antigen (or antigens) in genetically susceptible individuals.
5) The incidence of sarcoidosis varies widely across different ethnic and racial groups around the world. The highest annual incidence of sarcoidosis has been observed in northern European countries (5 to 40 cases per 100,000 people). In Japan, the annual incidence ranges from 1 to 2 cases per 100,000 people and peaks in the third decade of life. In Korea, the incidence was less than 1 case per 100,000 people, with the most common symptoms being respiratory (42%) in nature and the most frequently affected organs being the lungs (87%) and the skin (31%). The adjusted annual incidence among black Americans is roughly three times that of white Americans (35.5 cases per 100,000, as compared with 10.9 per 100,000). In addition to the reactivation of scars that developed following previous wounds, scar sarcoidosis has been reported at the sites of previous intramuscular injections, blood donation puncture, tattoo, and herpes zoster; in regions damaged during ritual sacrifice; and at the sites of allergen extract placement as a form of desensitization treatment and following hyaluronic acid injection and laser surgery. In general, scar sarcoidosis involves different skin levels. In most cases, the superficial and deep dermis is involved. Incision biopsy is needed to provide a diagnosis. Further investigations of systemic involvement in scar sarcoidosis should be performed in future studies. 10) 
